KYOWA KIRIN CO., LTD.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-06-26
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT00344409
- Locations
- π―π΅
Shikoku region, Ehime, Japan
π―π΅Kyusyu region, Fukuoka, Kagoshima, Japan
π―π΅Chugoku region, Hiroshima, Tottori, Japan
Safety Study of AMG 531 in Japanese Subjects With ITP
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-03-22
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT00305435
To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 630
- Registration Number
- NCT00273468
Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
- First Posted Date
- 2005-12-09
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 139
- Registration Number
- NCT00263575
- Locations
- πΊπΈ
Carolinas Pain Institute, Winston-Salem, North Carolina, United States
Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
- First Posted Date
- 2005-12-07
- Last Posted Date
- 2009-06-04
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Registration Number
- NCT00262678
- Locations
- πΊπΈ
Carolinas Pain Institute, Winston-Salem, North Carolina, United States
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2012-08-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT00250393
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-05-23
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 75
- Registration Number
- NCT00199355
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 405
- Registration Number
- NCT00199394
- Locations
- π¬π§
Kyowa Hakko UK Ltd., Slough, Berkshire, United Kingdom
Β© Copyright 2024. All Rights Reserved by MedPath